Finasterid-unterstützte Diagnostik des Prostatakarzinoms bei Patienten mit BPH
- Conditions
- Adenoma of the prostate, elevated serum-PSA value
- Registration Number
- EUCTR2005-002371-33-DE
- Lead Sponsor
- rologische Partnerschaft
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
- patients with elevated serum-PSA value
- Negative biopsy (min. sixfold), max. 2-12 months prior to inclusion
- Existence of enlargement of the prostate (>25 ml)
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- former or current use of 5-alpha reductase inhibitors
- proof of prostate cancer
- acute prostatitis
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method